Sequenom Corp fka SQNM

[surf1944]

7:09AM Sequenom announces publication acceptance of manuscript from age-related macular degeneration validation study (SQNM) 7.14 : Co announces the acceptance for publication of the manuscript, "Clinical Validation of a Genetic Model to Estimate the Risk of Developing Choroidal Neovascular Age-related Macular Degeneration." The article will appear in the June issue of Human Genomics. The study, conducted by the company's wholly-owned subsidiary, Sequenom Center for Molecular Medicine, was modeled using ~2000 case and control samples obtained from the University of Iowa, the University of Utah, Harvard University, Columbia University and the University of Melbourne.